Alfred J. Novak - Oct 21, 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Director
Signature
/s/ Alfred J. Novak
Stock symbol
KTTA
Transactions as of
Oct 21, 2022
Transactions value $
$0
Form type
4
Date filed
10/24/2022, 10:15 AM
Previous filing
Sep 20, 2022
Next filing
Mar 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTTA Stock Option (to acquire Common Stock) Award $0 +100K $0.00 100K Oct 21, 2022 Common Stock 100K $1.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 100,000 stock options. The stock options have a ten-year term and vest over two years, subject to Mr. Novak's continued service as a director, one-half vesting on the first anniversary of the grant date, and the remaining 50% vesting on the second anniversary of the grant date.